InMed Provides Update on Management Changes

Stock Information for InMed Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
InMed to Present at H.C. Wainwright 25th Annual Global Investment Conference
InMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ET
InMed Provides Update on BayMedica Rare Cannabinoid Business
InMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis Bullosa
InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
InMed to Participate in Upcoming Virtual Investor Events

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.